Certara, Inc.

CERT - Financial Snapshot

Healthcare sector | Health Information Services industry

View on:
Ranks:

Metrics for CERT

Price $6.67
Shares Outstanding 155.56M
All-Time Low $4.99
52-Week Low $4.99

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
⇒ cashValuePerShare = ((149,484,000 - 483,324,000) / 155,564,608) = -2.146
Net Current Assets / Share $-1.37
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
⇒ netCurrentAssetsPerShare = ((270,560,000 - 483,324,000) / 155,564,608) = -1.3677
Net Tangible Assets / Share $0
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
⇒ netTangibleAssetsPerShare = ((1,500,368,000 - 1,204,016,000 - 483,324,000) / 155,564,608) = -1.2
Avg CA Burn (Quarterly %) -14.14% (as of 7-14-2026)

Earning Metrics

Max Earning Power / Share $0.98
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
⇒ maxEarningPowerPerShare = ((16,087,000 / 0.105) / 155,564,608) = 0.9849
Adjusted Earning Power $-0.54
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((-8,763,000 / 0.105) / 155,564,608) = -0.5365
Non-Cash Charges to Market Cap 1.84%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Data as of: Price 07-14-26 16:00 ET, Balance Sheet 2026-03-31, Income Statement 2026-03-31, Cash Flow 2026-03-31

Indicators

Dividend indicators Value Date
Current Dividend Streak No 7-14-2026
Consecutive Years Paid No 7-14-2026
Pays Dividend No 7-14-2026
Income indicators Value Date
Current Dividend Streak No 7-14-2026
EBITDA Positive Yes 7-14-2026
Net Income Positive No 7-14-2026

Metric History Explorer

Pick a metric to view its history table and chart.

Tangible Book Value Per Share History

Formula: Tangible Book Value / shares from balance statements. Includes 2 quarterly.

Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).

Report Date Period TBV / Share Tangible Book Value Shares Used
2026-03-31 Quarterly $-1.22 -187M ($-186,972,000) 153.3M (153,325,078)
2025-12-31 Quarterly $-0.99 -158M ($-157,992,000) 159.1M (159,139,562)

Dividend Payments

Historical cash dividends per share from Yahoo ex-dividend dates.

Date Dividend / Share
No dividend payment history available yet

Shares Outstanding Changes

Date Shares Outstanding Delta
No recent share changes

Short Interest Changes

Latest short-interest change: 29,382,164 shares (29.26% of float) | Days to cover: 5.99

Date Short Interest Delta Δ %
2026-07-13 29,382,164 shares +850,863 +2.98%
2026-06-26 28,531,301 shares -218,893 -0.76%
2026-06-10 28,750,194 shares +3,470,941 +13.73%
2026-05-28 25,279,253 shares +1,157,950 +4.80%

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.